Danica Pension Livsforsikringsaktieselskab Takes Position in Danaher Corporation $DHR

Danica Pension Livsforsikringsaktieselskab purchased a new stake in shares of Danaher Corporation (NYSE:DHR) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 160,030 shares of the conglomerate’s stock, valued at approximately $31,728,000.

Several other large investors have also recently added to or reduced their stakes in DHR. Kestra Private Wealth Services LLC lifted its position in shares of Danaher by 0.3% in the 3rd quarter. Kestra Private Wealth Services LLC now owns 15,421 shares of the conglomerate’s stock worth $3,057,000 after buying an additional 48 shares during the last quarter. White Pine Capital LLC grew its position in shares of Danaher by 1.4% during the 2nd quarter. White Pine Capital LLC now owns 3,494 shares of the conglomerate’s stock valued at $690,000 after buying an additional 49 shares during the last quarter. SOL Capital Management CO raised its stake in Danaher by 2.8% during the third quarter. SOL Capital Management CO now owns 1,829 shares of the conglomerate’s stock worth $363,000 after acquiring an additional 50 shares during the period. Purkiss Capital Advisors LLC raised its stake in Danaher by 3.9% during the third quarter. Purkiss Capital Advisors LLC now owns 1,327 shares of the conglomerate’s stock worth $263,000 after acquiring an additional 50 shares during the period. Finally, TCTC Holdings LLC lifted its holdings in Danaher by 0.7% in the third quarter. TCTC Holdings LLC now owns 7,439 shares of the conglomerate’s stock worth $1,475,000 after acquiring an additional 51 shares during the last quarter. 79.05% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In related news, EVP Gregory M. Milosevich sold 1,320 shares of the stock in a transaction dated Thursday, February 19th. The shares were sold at an average price of $208.01, for a total value of $274,573.20. Following the completion of the transaction, the executive vice president owned 5,099 shares in the company, valued at $1,060,642.99. This represents a 20.56% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. 11.20% of the stock is owned by insiders.

Danaher Price Performance

Shares of NYSE:DHR opened at $195.00 on Wednesday. The firm’s 50 day moving average is $217.08 and its two-hundred day moving average is $215.30. The firm has a market capitalization of $137.89 billion, a P/E ratio of 38.69, a PEG ratio of 2.59 and a beta of 0.93. The company has a current ratio of 1.87, a quick ratio of 1.51 and a debt-to-equity ratio of 0.35. Danaher Corporation has a 52 week low of $171.00 and a 52 week high of $242.80.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Tuesday, January 27th. The conglomerate reported $2.23 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.14 by $0.09. The business had revenue of $6.84 billion during the quarter, compared to analyst estimates of $6.79 billion. Danaher had a return on equity of 10.81% and a net margin of 14.71%.The business’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same period in the prior year, the company posted $2.14 EPS. Analysts anticipate that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 24th. Investors of record on Friday, March 27th will be paid a dividend of $0.40 per share. This is an increase from Danaher’s previous quarterly dividend of $0.32. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date is Friday, March 27th. Danaher’s dividend payout ratio (DPR) is presently 25.40%.

Analyst Ratings Changes

Several equities analysts have recently commented on the company. Wall Street Zen raised Danaher from a “hold” rating to a “buy” rating in a report on Saturday, November 22nd. The Goldman Sachs Group cut their price target on Danaher from $270.00 to $265.00 and set a “buy” rating on the stock in a report on Thursday, January 29th. Evercore restated an “outperform” rating and set a $254.00 price objective on shares of Danaher in a research report on Wednesday, January 28th. Robert W. Baird set a $251.00 price objective on Danaher in a research note on Thursday, January 29th. Finally, HSBC increased their target price on Danaher from $255.00 to $270.00 and gave the stock a “buy” rating in a research report on Monday, December 1st. Nineteen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $253.55.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.